AIMS/HYPOTHESIS: The incidence of type 1 diabetes varies according to age, sex and season of diagnosis. We investigated whether these and other clinical, biological and anthropometric parameters were correlated with residual beta cell function in newly diagnosed patients, since it is possible that the nature of external and/or genetic disease accelerators may be (partly) reflected in the inaugural disease presentation. MATERIALS AND METHODS: The correlates of random C-peptide levels sampled shortly after diagnosis (median [interquartile range]: 3 [0-14] days) were studied by multivariate analysis in 1,883 islet-antibody-positive diabetic patients aged <40 years who were diagnosed between 1989 and 2000. RESULTS: Higher C-peptide levels (abov...
Islet cell antibodies (ICA), fasting plasma C-peptide, and HbA(1c) were evaluated up to 10 years aft...
BACKGROUND: This study was undertaken to observe the changes of basal C-peptide level and to compare...
AIMS/HYPOTHESIS: Recent studies have demonstrated that residual beta cells may be present in some pe...
Background There are seasonal variations and gender differences in incidence of type 1 diabetes (T1D...
Aims/hypothesis: We studied the decline of C-peptide during the first year after diagnosis of Type 1...
C-peptide secretion is currently the only available clinical biomarker to measure residual β-cell fu...
Background: Contrary to the presumption that type 1 diabetes leads to an absolute insulin deficiency...
OBJECTIVE: To evaluate serum C-peptide in 88 patients from a multiethnic population with Type-1 diab...
Aims: To describe the factors predicting c‐peptide within 60 days of diagnosis, in a multi‐ethnic, i...
OBJECTIVE - To investigate whether the presence of antibody markers at diagnosis could help predict ...
Objective: To identify the factors associated with residual C peptide production at least 10 years a...
Objective: The aim of this study is to identify risk factors for the loss of measurable plasma C-pep...
There is increasing recognition that type 1 diabetes (T1D) is a heterogeneous disease, driven by div...
IntroductionThe progression to insulin deficiency in type 1 diabetes is heterogenous. This study aim...
The inability to produce insulin endogenously precipitates the clinical symptoms of type 1 diabetes ...
Islet cell antibodies (ICA), fasting plasma C-peptide, and HbA(1c) were evaluated up to 10 years aft...
BACKGROUND: This study was undertaken to observe the changes of basal C-peptide level and to compare...
AIMS/HYPOTHESIS: Recent studies have demonstrated that residual beta cells may be present in some pe...
Background There are seasonal variations and gender differences in incidence of type 1 diabetes (T1D...
Aims/hypothesis: We studied the decline of C-peptide during the first year after diagnosis of Type 1...
C-peptide secretion is currently the only available clinical biomarker to measure residual β-cell fu...
Background: Contrary to the presumption that type 1 diabetes leads to an absolute insulin deficiency...
OBJECTIVE: To evaluate serum C-peptide in 88 patients from a multiethnic population with Type-1 diab...
Aims: To describe the factors predicting c‐peptide within 60 days of diagnosis, in a multi‐ethnic, i...
OBJECTIVE - To investigate whether the presence of antibody markers at diagnosis could help predict ...
Objective: To identify the factors associated with residual C peptide production at least 10 years a...
Objective: The aim of this study is to identify risk factors for the loss of measurable plasma C-pep...
There is increasing recognition that type 1 diabetes (T1D) is a heterogeneous disease, driven by div...
IntroductionThe progression to insulin deficiency in type 1 diabetes is heterogenous. This study aim...
The inability to produce insulin endogenously precipitates the clinical symptoms of type 1 diabetes ...
Islet cell antibodies (ICA), fasting plasma C-peptide, and HbA(1c) were evaluated up to 10 years aft...
BACKGROUND: This study was undertaken to observe the changes of basal C-peptide level and to compare...
AIMS/HYPOTHESIS: Recent studies have demonstrated that residual beta cells may be present in some pe...